Literature DB >> 6489766

Gas-mediated vitreous compression: an experimental alternative to mechanized vitrectomy.

R J Thresher, M Ehrenberg, R Machemer.   

Abstract

We have developed a simple technique in rabbit and baboon eyes that utilizes intravitreally injected perfluoropropane gas, which expands slowly to efficiently compress and displace nearly completely the vitreous body. There is cataract formation after extended contact of the gas bubble with the lens. However, it is rapidly reversible by reducing the duration of lens contact (gas-fluid exchange) and by using young animals. No long-term alterations in intraocular pressure or retinal function were observed, as determined by electroretinography, during the 4-month test period. Gross examination and scanning electron microscopy revealed that the vitreous cavity, shortly after full expansion of the gas bubble, was practically free of collagen. The vitreous body had been detached from most of the retina and compressed into a collagenous strand between the optic nerve head and lens in the rabbit eyes, and there was also a dense collagen accumulation on the inferior retinal surface and anterior vitreous base in the rabbits and the baboon. Large areas of the retina and medullary wings were stripped of overlying collagen. By the end of 4 months, the compressed vitreous body had expanded to become an irregular structure that remained separated from the retina in areas of previous detachment. Mechanized vitrectomy is a difficult procedure often needed in experimental work. We believe that the vitreous compression and gas-fluid exchange technique is a valid alterative to a mechanical approach. We also believe that we have a model that simulates the human situation of posterior vitreous detachment and vitreous syneresis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6489766     DOI: 10.1007/bf02134139

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  10 in total

1.  Day-to-day variations in the ERG of humans and rabbits.

Authors:  B E SPIVEY; J T PEARLMAN
Journal:  Am J Ophthalmol       Date:  1963-05       Impact factor: 5.258

2.  Effect of intraocular gas on intraocular pressure.

Authors:  J D Aronowitz; R F Brubaker
Journal:  Arch Ophthalmol       Date:  1976-07

3.  Dynamics of intravitreal sulfur hexafluoride gas.

Authors:  G W Abrams; H F Edelhauser; T M Aaberg; L H Hamilton
Journal:  Invest Ophthalmol       Date:  1974-11

4.  Practical rabbit electroretinography.

Authors:  T Lawwill
Journal:  Am J Ophthalmol       Date:  1972-07       Impact factor: 5.258

5.  Intravitreal behavior of perfluorocarbons.

Authors:  A Lincoff; I Kreissig
Journal:  Dev Ophthalmol       Date:  1981

6.  The use of intraocular gases. The results of sulfur hexafluoride gas in retinal detachment surgery.

Authors:  W I Sabates; G W Abrams; D E Swanson; E W Norton
Journal:  Ophthalmology       Date:  1981-05       Impact factor: 12.079

7.  Intravitreal longevity of three perfluorocarbon gases.

Authors:  H Lincoff; J Mardirossian; A Lincoff; P Liggett; T Iwamoto; F Jakobiec
Journal:  Arch Ophthalmol       Date:  1980-09

8.  Sulfur hexafluoride in owl monkey vitreous cavity.

Authors:  E Fineberg; R Machemer; P Sullivan; E W Norton; D Hamasaki; D Anderson
Journal:  Am J Ophthalmol       Date:  1975-01       Impact factor: 5.258

9.  Vitreous hemorrhage nontoxic to retina as a stimulator of glial and fibrous proliferation.

Authors:  M Ehrenberg; R J Thresher; R Machemer
Journal:  Am J Ophthalmol       Date:  1984-05       Impact factor: 5.258

10.  Intravitreal expansion of perfluorocarbon bubbles.

Authors:  A Lincoff; D Haft; P Liggett; C Reifer
Journal:  Arch Ophthalmol       Date:  1980-09
  10 in total
  18 in total

1.  Critical involvement of extracellular ATP acting on P2RX7 purinergic receptors in photoreceptor cell death.

Authors:  Shoji Notomi; Toshio Hisatomi; Takaaki Kanemaru; Atsunobu Takeda; Yasuhiro Ikeda; Hiroshi Enaida; Guido Kroemer; Tatsuro Ishibashi
Journal:  Am J Pathol       Date:  2011-10-08       Impact factor: 4.307

2.  Alterations in rabbit vitreal fine structure following C3F8 injection.

Authors:  B Panessa-Warren; J M Maisel; J Warren
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

3.  Classification of the stages of proliferative vitreoretinopathy in a refined experimental model in the rabbit eye.

Authors:  T Hida; D B Chandler; S M Sheta
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

4.  The treatment of giant tear detachments using retrohyaloidal perfluorocarbon gases without drainage or vitrectomy.

Authors:  I Kreissig; H Lincoff; A Stanowsky
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

5.  Gas vitrectomy in a primate model.

Authors:  H Lincoff; I Kreissig; F Jakobiec; T Iwamoto; J Vitolo; R Shapiro
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

6.  Local effects of different perfluorochemical agents.

Authors:  A J Augustin; M Spitznas; F H Koch; T Böker; J Lutz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-01       Impact factor: 3.117

7.  Experimental retinal tolerance to very low viscosity silicone oil (100 cs) as a vitreous substitute compared to higher viscosity silicone oil (5000 cs).

Authors:  M Soheilian; G A Peyman; T Moritera; H Wafapoor
Journal:  Int Ophthalmol       Date:  1995       Impact factor: 2.031

8.  Daunorubicin treatment in a refined experimental model of proliferative vitreoretinopathy.

Authors:  J A Khawly; P Saloupis; D L Hatchell; R Machemer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

9.  Ocular toxicity of daunomycin: effects of subdivided doses on the rabbit retina after vitreous gas compression.

Authors:  U H Steinhorst; D L Hatchell; E P Chen; R Machemer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-10       Impact factor: 3.117

10.  A refined experimental model for proliferative vitreoretinopathy.

Authors:  D B Chandler; F A Quansah; T Hida; R Machemer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.